Regulations for the issue of Lot Release Certificate for Vaccines & Sera No.1 of 2019
Application form for Lot Release certificate for Vaccines & Sera
Application form for Quality Testing of Vaccines & Sera
Temperature monitoring data during transportation of Vaccines & Sera
| Serial no | Lot release certificate no | Product name | Manufacturer | Lot no | Manufacturing date | Expiry date | Date of release | No of vials released | Remarks |
| 1 | 1/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 06.01.2022 | 58,500 | |
| 2 | 2/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 06.01.2022 | 63,960 | |
| 3 | 3/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM5450 | 05.11.2021 | 31.07.2022 | 06.01.2022 | 68,250 | |
| 4 | 4/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM5450 | 05.11.2021 | 31.07.2022 | 06.01.2022 | 64,545 | |
| 5 | 5/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM5450 | 05.11.2021 | 31.07.2022 | 06.01.2022 | 68,250 | |
| 6 | 6/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN5436 | 08.11.2021 | 31.07.2022 | 21.01.2022 | 75,660 | |
| 7 | 7/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN5436 | 08.11.2021 | 31.07.2022 | 21.01.2022 | 87,750 | |
| 8 | 8/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM5450 | 05.11.2021 | 31.07.2022 | 21.01.2022 | 68,250 | |
| 9 | 9/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9281 | 17.11.2021 | 31.07.2022 | 21.01.2022 | 20,475 | |
| 10 | 10/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9281 | 17.11.2021 | 31.07.2022 | 13.01.2022 | 58,500 | |
| 11 | 11/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9092 | 17.11.2021 | 31.07.2022 | 01.02.2022 | 71,760 | |
| 12 | 12/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9092 | 17.11.2021 | 31.07.2022 | 01.02.2022 | 58,500 | |
| 13 | 13/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 14 | 14/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 15 | 15/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 16 | 16/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 17 | 17/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 18 | 18/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 27.01.2022 | 58,500 | |
| 19 | 19/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 01.02.2022 | 58,500 | |
| 20 | 20/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 01.02.2022 | 58,500 | |
| 21 | 21/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 03.02.2022 | 195 | |
| 22 | 22/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 03.02.2022 | 58,500 | |
| 23 | 23/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 03.02.2022 | 52,455 | |
| 24 | 24/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN2898 | 24.11.2021 | 31.07.2022 | 03.02.2022 | 65,910 | |
| 25 | 25/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 22.02.2022 | 5,850 | |
| 26 | 26/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN5436 | 08.11.2021 | 31.07.2022 | 22.02.2022 | 87,750 | |
| 27 | 27/2022/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FN5436 | 08.11.2021 | 31.07.2022 | 22.02.2022 | 87,750 | |
| 28 | 28/2022/LR | Poliomyelitis Vaccine Oral Bivalent Type 1 and 3 (Live attenuated) 20 dose vial | Sanofi Pasteur, France | U3K801V | 06.2020 | 07.2023 | 14.03.2022 | 37,500 | |
| 29 | 29/2022/LR | Pneumococcal Conjugate Vaccine (10 valent) | GlaxoSmithKline Biologicals SA 89,Rue de I' Institut, BE 1330,Rixensart,Belgium | ASPNB339BV | APR 2021 | MAR 2025 | 28.02.2022 | 28,000 | |
| 30 | 30/2022/LR | Human Papillomavirus Quadrivalent Vaccine Gardasil Single dose vial | Merck Sharp & Dohme Corp., Netherland | G0033A | 05.2021 | 05.2024 | 07.03.2022 | 150,000 | |
| 31 | 31/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) - Priorix Single dose vial | GlaxoSmithKline Biologicals Rixensart, Belgium | Package: A69CF358A Vial: A69FF358A | Sep 2021 | Aug 2023 | 08.03.2022 | 1,235 | |
| 32 | 32/2022/LR | Snake Venom Antiserum I.P. | Bharat Serums and Vaccines Ltd., India | A05321084 A05321085 A05321086 A05321087 A05321088 | 10/2021 10/2021 10/2021 10/2021 10/2021 | 09/2025 09/2025 09/2025 09/2025 09/2025 | 14.03.2022 | 8,550 8,560 8,560 8,570 760 | |
| 33 | 33/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0130N040A | OCT 2021 | MAR 2024 | 14.03.2022 | 4,000 | |
| 34 | 34/2022/LR | Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b conjugate vaccine Adsorbed Single dose vial | Serum Institute of India Pvt. Ltd., India | 2851X026F | SEP 2021 | FEB 2024 | 14.03.2022 | 4,005 | |
| 35 | 35/2022/LR | Inactivated Poliomyelitis vaccine 05 dose vial (25 dose as ID adm) | Bilthoven Biologicals B.V., The Netherlands | 2124006A 2121002A 2123004A | Not given | 18.05.2024 06.04.2024 29.04.2024 | 23.03.2022 | 10,080 | |
| 36 | 36/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) - Priorix Single dose vial | GlaxoSmithKline Biologicals Rixensart, Belgium | Package: A69CF413A Vial: A69FF413A | Jan 2022 | Dec 2023 | 23.03.2022 | 15,280 | |
| 37 | 37/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0130N040A | OCT 2021 | MAR 2024 | 24.03.2022 | 20,005 | |
| 38 | 38/2022/LR | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd. India | 0371G079 | Nov 2021 | Oct 2023 | 24.03.2022 | 2,005 | |
| 39 | 39/2022/LR | Adsorbed Tetanus Vaccine B. P. Single dose ampoule | Serum Institute of India Pvt. Ltd., India | 2591I003C 2591I003D | July 2021 | June 2024 | 24.03.2022 | 46,020 | |
| 40 | 40/2021/LR | Influenza Vaccine (Surface antigen, inactivated) Influvac Single dose prefilled syringe | Abbott Biologicals B.V., The Netherlands | A01 | Dec 2021 | Nov 2022 | 05.04.2022 | 15,000 | |
| 41 | 41/2022/LR | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2331L027C | SEP 2021 | AUG 2024 | 08.04.2022 | 20,000 | |
| 42 | 42/2022/LR | Measles, Mumps and Rubella vaccine Live attenuated (Freeze Dried) Ten doses vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0161N021 | OCT 2021 | MAR 2024 | 08.04.2022 | 4,100 | |
| 43 | 43/2022/LR | Adsorbed Tetanus Vaccine B. P. 10 dose vial | Biological E Ltd., India | 220800321B | JUNE 2021 | May 2024 | 05.05.2022 | 200,000 | |
| 44 | 44/2022/LR | Combined Diphtheria,Tetanus, Acellular Pertussis, Hepatitis B and Inactivated Polio Vaccine + Adsorbed Haemophilus influenzae type B Vaccine, Infanrix hexa Single dose vial | GlaxoSmithKline Biologicals, Belgium | A21CE109A | JUNE 2021 | MAY 2024 | 12.05.2022 | 17,820 | |
| 45 | 45/2022/LR | Measles, Mumps and Rubella vaccine Live attenuated (Freeze Dried) Ten doses vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0161W022 | FEB 2022 | JULY 2024 | 23.05.2022 | 23900 | |
| 46 | 46/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0131N068B | JAN 2021 | JUN 2024 | 25.05.2022 | 18010 | |
| 47 | 47/2022/LR | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2331L036D | OCT 2021 | SEP 2024 | 25.05.2022 | 1,010 | |
| 48 | 48/2022/LR | Hepatitis A Vaccine (inactivated) Havrix Prefilled syringe Single dose vial | GlaxoSmithKline Biologicals , Belgium | AHAVC109AC | NOV 2021 | OCT 2024 | 30.05.2022 | 2,750 | |
| 49 | 49/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0131N068B | JAN 2022 | JUN 2024 | 01.06.2022 | 18,010 | |
| 50 | 50/2022/LR | Rabies Antiserum BP 1000 IU/5ML | VINS BIOPRODUCTS LTD.,806,ESSJAY HOUSE,ROAD NO 3,BANJARA HILLS,HYDERABAD 500 034,INDIA | 08AR22005 08AR22006 08AR22007 | March 2022 | 28 Feb 2024 | 17.06.2022 | 5,756 18,670 5,574 | |
| 51 | 51/2022/LR | Combined Diphtheria,Tetanus, Acellular Pertussis, Hepatitis B and Inactivated Polio Vaccine + Adsorbed Haemophilus influenzae type B Vaccine, Infanrix hexa Single dose vial | GlaxoSmithKline Biologicals, Belgium | A21CE122C | 44470 | 45536 | 23.06.2022 | 16,640 | |
| 52 | 52/2022/LR | Live Attenuated Rota Virus Vaccine (Oral) Single dose plastic tube | GalaxoSmithKline Biologicals SA | AROLD422AA | 11.2021 | 10.2024 | 20.06.2022 | 25,049 plastic tubes | |
| 53 | 53/2022/LR | Measles, Mumps and Rubella vaccine (Live attenuated) - Priorix Single dose vial | GlaxoSmithKline Biologicals Rixensart, Belgium | A69CF450A | Aprial 2022 | March 2023 | 01.07.2022 | 16,060 | |
| No. of vaccine/serum lots released = 53 | |||||||||
| No. of vaccine/serum lots failed to pass lot release = 0 | |||||||||
| No. of vaccine/serum lots tested following a break in the cold chain, adverse effects following immunization or vaccine failure = 0 | |||||||||
| Serial no | Lot release certificate no | Product name | Manufacturer | Lot no | Manufacturing date | Expiry date | Date of release | No of vials released | Remarks |
| 51 | 49/2021/LR | Adsorbed Tetanus Vaccine B.P. Single dose ampoules | Serum Institute of India Ltd. India | 2590I006B 2590I003D | Sep 2020 | Aug 2023 | 04.08.2021 | 157,640 140,000 | |
| 52 | 50/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1145 202106B1147 202106B1149 202106B1150 | 03.06.2021 | 02.06.2023 | 02.07.2021 | 150,000 50,000 150,000 150,000 | |
| 53 | 51/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1160 202106B1165 202106B1177 202106B1178 | 04.06.2021 04.06.2021 05.06.2021 05.06.2021 | 03.06.2023 03.06.2023 04.06.2023 04.06.2023 | 05.07.2021 | 500,000 | |
| 54 | 52/2021/LR | Japanese Encephalitis Vaccine, Live 5 dose vial | Chengdu Institute of Biological Products Co. Ltd., China | 202011C015-2 | 07.11.2020 | 06.11.2022 | 06.07.2021 | 55,000 | |
| 55 | 53/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FC5029 | 26.05.2021 | 31.10.2021 | 06.07.2021 | 4,333 | |
| 56 | 54/2021/LR | Gam-COVID-Vac Component 1 Single dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | I-1050521 | May 2021 | Nov 2021 | 07.07.2021 | 50,000 | |
| 57 | 55/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1269 202106B1270 202106B1271 202106B1276 | 12.06.2021 | 11.06.2023 | 11.07.2021 | 85,000 155,000 155,000 105,000 | |
| 58 | 56/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1258 202106B1259 202106B1260 202106B1269 | 11.06.202111.06.202111.06.2021 12.06.2021 | 10.06.2023 10.06.2023 10.06.2023 11.06.2023 | 12.07.2021 | 155,000 155,000 120,000 70,000 | |
| 59 | 57/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FF4222 | 02.06.2021 | 31.10.2021 | 12.07.2021 | 4,485 | |
| 60 | 58/2021/LR | COV-19(Moderna);MDV5 | Moderna One uplandwood,MA 02062 Catalent 1300 S DriveBloomington, IN 47403 | 028D21A 066D21A | 29.04.2021 09.05.2021 | 29.11.2021 09.12.2021 | 17.07.2021 | 107,150 | |
| 61 | 59/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FF4222 | 02.06.2021 | 31.10.2021 | 19.07.2021 | 10,335 | |
| 62 | 60/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1440 202106B1449 202106B1450 202106B1451 | 22.06.2021 23.06.2021 23.06.2021 23.06.2021 | 21.06.2023 22.06.2023 22.06.2023 22.06.2023 | 22.07.2021 | 103,200 155,000 155,000 86,800 | |
| 63 | 61/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1451 202106B1452 202106B1453 202106B1454 | 23.06.2021 23.06.2021 23.06.2021 23.06.2021 | 22.06.2023 22.06.2023 22.06.2023 22.06.2023 | 22.07.2021 | 68,200 155,000 155,000 121,800 | |
| 64 | 62/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FF8871 | 10.06.2021 | 30.11.2021 | 26.07.2021 | 15,015 | |
| 65 | 63/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202106B1512 202106B1518 202106B1519 202106B1520 202106B1528 202106B1529 | 27.06.2021 27.06.2021 27.06.2021 27.06.2021 28.06.2021 28.06.2021 | 26.06.2023 26.06.2023 26.06.2023 26.06.2023 27.06.2023 2706.2023 | 27.07.2021 | 156,000 150,000 150,000 150,000 156,000 38,000 | |
| 66 | 64/2021/LR | COVID-19 (SARS-CoV-2) Vaccine (Recombinant Chimpanzee Adenovirus Vector) [Astrazeneca] | KM Biologics Co,Ltd.1-6-1 Okubo,Kita-ku,Kumamoto-shi,Kumamoto 860-8568,Japan | K008A K008B | 18.04.2021 | 17.10.2021 | 01.08.2021 | 16,800 56,046 | |
| 67 | 65/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FF8871 | 07.2021 | 11.2021 | 02.08.2021 | 17,550 | |
| 68 | 66/2021/LR | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd. India | 0371G031 | Apr 2021 | Mar 2023 | 04.08.2021 | 2,405 | |
| 69 | 67/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B1680 202107B1684 202107B1685 202107B1686 | 07.07.2021 07.07.2021 07.07.2021 07.07.2021 | 06.07.2023 06.07.2023 06.07.2023 06.07.2023 | 06.08.2021 | 67,500 155,000 155,000 155,000 | |
| 70 | 68/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B1686 202107B1699 202107B1700 202107B1701 202107B1702 | 07.07.2021 08.07.2021 08.07.2021 08.07.2021 08.07.2021 | 06.07.2023 07.07.2023 07.07.2023 07.07.2023 07.07.2023 | 06.08.2021 | 75,000 155,000 155,000 82,500 | |
| 71 | 69/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B1717 202107B1719 | 09.07.2021 09.07.2021 | 08.07.2023 08.07.2023 | 13.08.2021 | 54,500 15,600 | |
| 72 | 70/2021/LR | COVID-19 (SARS-CoV-2) Vaccine (Recombinant Chimpanzee Adenovirus Vector) [Astrazeneca] | KM Biologics Co,Ltd.1-6-1 Okubo,Kita-ku,Kumamoto-shi,Kumamoto 860-8568,Japan | D011A K010B | 25.04.2021 | 09.11.2021 24.10.2021 | 08.08.2021 | 16,640 56,098 | |
| 73 | 71/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B1719 202107B1734 202107B1735 202107B1736 202107B1737 202107B1738 202107B1752 | 09.07.2021 10.07.2021 10.07.2021 10.07.2021 10.07.2021 10.07.2021 11.07.2021 | 08.07.2023 09.07.2023 09.07.2023 09.07.2023 09.07.2023 09.07.2023 10.07.2023 | 13.08.2021 | 109,400 156,000 156,000 156,000 150,000 52,500 150,000 | |
| 74 | 72/2021/LR | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2331X003B | March 2021 | Feb 2024 | 13.08.2021 | 14,000 | |
| 75 | 73/2021/LR | Diphtheria and Tetanus Vaccine Adsorbed (Pediatric) 10 dose vial | Serum Institute of India Pvt. Ltd., India | 2450L006 | Dec 2020 | Nov 2023 | 13.08.2022 | 20,000 | |
| 76 | 74/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FD0350 | 12.05.2021 | 31.10.2021 | 12.08.2021 | 12,675 | |
| 77 | 75/2021/LR | Gam-COVID-Vac Component II TWO dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | II-370721 | July 2021 | Jan 2022 | 13.06.2022 | 7,500 | |
| 78 | 76/2021/LR | Combined Diphtheria,Tetanus, Acellular Pertussis, Hepatitis B and Inactivated Polio Vaccine + Adsorbed Haemophilus influenzae type B Vaccine, Infanrix hexa Single dose vial | GlaxoSmithKline Biologicals, Belgium | A21CD950B | Dec 2020 | Nov 2023 | 17.08.2021 | 14,690 | |
| 79 | 77/2020/LR | Diphtheria, Tetanus and Pertussis (acellular,component) Vaccine (Adsorbed, reduced antigen(s) content) Boostrix Single dose vial | GlaxoSmithKline Biologicals, Belgium | AC37B392AH | Aug 2020 | July 2022 | 20.08.2021 | 12,760 | |
| 80 | 78/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FD0350 | 12.05.2021 | 31.10.2021 | 18.08.2021 | 12,480 | |
| 81 | 79/2021/LR | Human Papillomavirus Quadrivalent Vaccine Gardasil Single dose vial | Merck Sharp & Dohme Corp., Netherland | G0026A | 03.2021 | 03.2024 | 01.09.2021 | 150,000 | |
| 82 | 80/2021/LR | Inactivated Rabies Vaccine- VERORAB | Sanofi Pasteur,14 Espace Henty Vallee,69007 Lyon,France | U1A641M | 04.03.2021 | 28.02.2023 | 20.08.2021 | 3,000 | |
| 83 | 81/2021/LR | Recombinant Hepatitis B vaccine | Sanofi Pasteur,14 Espace Henty Vallee,69007 Lyon,France | UFX20005 | 20.07.2020 | 19.07.2023 | 20.08.2021 | 6,000 | |
| 84 | 82/2021/LR | Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b conjugate vaccine Adsorbed Single dose vial | Serum Institute of India Pvt. Ltd., India | 2850Y043C | Jun 2021 | Jun 2023 | 20.08.2021 | 1,205 | |
| 85 | 83/2021/LR | Haemophilus influenzae type b Conjugate Vaccine (Freez dried)) Single dose vial | Serum Institute of India Pvt. Ltd. India | 1140M024B | Jul 2020 | Jun 2023 | 20.08.2021 | 1,205 | |
| 86 | 84/2021/LR | Hepatitis B Vaccine (rDNA) Adult Single dose vial | Serum Institute of India Pvt. Ltd., India | 0341Q004C | Feb 2021 | Jan 2024 | 20.08.2021 | 505 | |
| 87 | 85/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FD0350 | 12.05.2021 | 31.10.2021 | 24.08.2021 | 12,675 | |
| 88 | 86/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B2027 202107B2029 202107B2030 202107B2031 | 28.07.2021 28.07.2021 28.07.2021 28.07.2021 | 27.07.2023 27.07.2023 27.07.2023 27.07.2023 | 24.08.2021 | 30,000 155,000 160,000 155,000 | |
| 89 | 87/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B2013 202107B2047 202107B2048 202107B2049 | 27.07.2021 30.07.2021 30.07.2021 30.07.2022 | 26.07.2023 29.07.2023 29.07.2023 29.07.2023 | 28.08.2021 | 42,960 159,230 159,510 138,300 | |
| 90 | 88/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 202107B2049 202107B2068 202107B2069 202107B2070 202107B2086 | 30.07.2021 31.07.2021 31.07.2021 31.07.2021 01.08.2021 | 29.07.2023 30.07.2023 30.07.2023 30.07.2023 31.07.2023 | 28.08.2021 | 17,920 160,760 160,710 159,990 620 | |
| 91 | 89/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FF5111 | 18.07.2021 | 31.12.2021 | 29.08.2021 | 16,770 | |
| 92 | 90/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Two doses vial | Beijing Institute of Biological Products Co. Ltd., China | 2021071932 2021071933 | 23.07.2021 23.07.2021 | 22.07.2023 22.07.2023 | 17.09.2021 | 300,000 | |
| 93 | 91/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FD0350 | 12.05.2021 | 31.10.2021 | 03.09.2021 | 2,925 | |
| 94 | 92/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FH4092 | 15.07.2021 | 31.12.2021 | 03.09.2021 | 17,745 | |
| 95 | 93/2021/LR | Gam-COVID-Vac Component II TWO dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | II-510821 | Aug 2021 | Feb 2022 | 01.09.2021 | 7,500 | |
| 96 | 94/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Five doses vial | Beijing Institute of Biological Products Co. Ltd., China | B2021082289 B2021082333 B2021082334 B2021082335 B2021082336 B2021082344 B2021082321 | 09.08.2021 11.08.2021 11.08.2021 11.08.2021 11.08.2021 12.08.2021 11.08.2021 | 08.08.2023 10.08.2023 10.08.2023 10.08.2023 10.08.2023 11.08.2023 10.08.2023 | 06.09.2021 | 130,910 131,810 131,150 130,740 131,260 43,560 570 | |
| 97 | 95/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Five doses vial | Beijing Institute of Biological Products Co. Ltd., China | B2021082320 B2021082321 | 11.08.2021 11.08.2021 | 10.08.2023 10.08.2023 | 06.09.2021 | 35,160 64,840 | |
| 98 | 96/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FG6272 | 02.08.2021 | 31.12.2021 | 08.09.2021 | 15,405 | |
| 99 | 97/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FJ3438 | 30.07.2021 | 31.12.2021 | 16.09.2021 | 12,285 | |
| 100 | 98/2021/LR | SARS-Co V-2 Vaccine (Vero Cell) Inactivated Five doses vial | Beijing Institute of Biological Products Co. Ltd., China | B2021082626 B2021082633 B2021082676 B2021082677 B2021082678 B2021082679 B2021082680 B2021082681 B2021082682 | 23.08.2021 23.08.2021 25.08.2021 25.08.2021 25.08.2021 25.08.2021 25.08.2021 25.08.2021 25.08.2021 | 22.08.2023 22.08.2023 24.08.2023 24.08.2023 24.08.2023 24.08.2023 24.08.2023 24.08.2023 24.08.2023 | 18.09.2021 | 20 19,250 76,410 65,050 112,690 131,740 131,240 131,870 131,730 | |
| 101 | 99/2021/LR | Gam-COVID-Vac Component II TWO dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | II-590821 | Aug 2021 | Feb 2022 | 21.09.2021 | 60,000 | |
| 102 | 100/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FJ5782 | 27.07.2021 | 31.12.2021 | 22.09.2021 | 12,285 | |
| 103 | 101/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK0115 | 09.08.2021 | 31.01.2022 | 29.09.2021 | 5,265 | |
| 104 | 102/2021/LR | Poliomyelitis Vaccine Oral Bivalent Type 1 and 3 (Live attenuated) 20 dose vial | Sanofi Pasteur, France | U3G581V U3G591V | 06.2020 | 05.2023 | 28.10.2021 | 40,000 | |
| 105 | 103/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FH8022 | 27.08.2021 | 31.01.2022 | 06.10.2021 | 67,275 | |
| 106 | 104/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FH8022 | 27.08.2021 | 31.01.2022 | 03.11.2022 | 15,990 | |
| 107 | 105/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FH8022 | 27.08.2021 | 31.01.2022 | 22.10.2021 | 49,920 | |
| 108 | 106/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FH6495 | 19.08.2021 | 31.01.2022 | 13.10.2021 | 50,700 | |
| 109 | 107/2020/LR | Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Menactra Single dose | Sanofi Pasteur Inc., USA | U7080AA | 24.08.2020 | 28.09.2022 | 11.10.2021 | 750 | |
| 110 | 108/2021/LR | Rabies Vaccine B.P. 'Rab' Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute (A division of Indian Immunologicals Ltd), Tamil Nadu, India | 21URAB026 21URAB027 | June 2021 July 2021 | May 2024 June 2024 | 13.10.2021 | 70,147 49,853 | |
| 111 | 109/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FJ4187 | 06.09.2021 | 28.02.2022 | 02.11.2021 | 50,700 | |
| 112 | 110/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL1072 | 03.09.2021 | 28.02.2022 | 28.10.2021 | 50,700 | |
| 113 | 111/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL1072 | 03.09.2021 | 28.02.2022 | 03.11.2021 | 50,895 | |
| 114 | 112/2021/LR | Adsorbed Tetanus Vaccine B. P. 10 dose vial | Biological E Ltd., India | 220800321B | Jun 2021 | May 2024 | 01.11.2021 | 20,000 | |
| 115 | 113/2021/LR | Diphtheria, Tetanus Pertussis (whole cell) Hepatitis B (r DNA) Haemophilus type b conjugate vaccine (Adsorbed) 10 dose vial | Biological E Ltd., India | 220103421A | Jun 2021 | Nov 2023 | 01.11.2021 | 50,000 | |
| 116 | 114/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM3802 | 30.09.2021 | 28.02.2022 | 12.11.2021 | 33,735 | |
| 117 | 115/2021/LR | Japanese Encephalitis Vaccine, Live 5 dose vial | Chengdu Institute of Biological Products Co. Ltd., China | 202103C001-2 | 24.03.2021 | 23.03.2023 | 02.12.2021 | 25,000 | |
| 118 | 116/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9360 | 06.10.2021 | 30.06.2022 | 02.12.2021 | 71,175 | |
| 119 | 117/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK8911 | 05.10.2021 | 30.06.2022 | 01.12.2021 | 2,145 | |
| 120 | 118/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK9412 | 04.10.2021 | 30.06.2022 | 02.12.2021 | 34,905 | |
| 121 | 119/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK9412 | 04.10.2021 | 30.06.2022 | 01.12.2021 | 71,175 | |
| 122 | 120/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK9412 | 04.10.2021 | 30.06.2022 | 01.12.2021 | 71,175 | |
| 123 | 121/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FK9412 | 04.10.2021 | 30.06.2022 | 01.12.2021 | 34,905 | |
| 124 | 122/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM9360 | 06.10.2021 | 30.06.2022 | 01.12.2021 | 32,760 | |
| 125 | 123/2021/LR | Measles, Mumps and Rubella vaccine (Live attenuated) - Priorix Single dose vial | GlaxoSmithKline Biologicals Rixensart, Belgium | Package: A69CF328A Vial: A69FF328A | Sep 2021 | Aug 2023 | 29.11.2021 | 15,600 | |
| 126 | 124/2021/LR | Measles, Mumps and Rubella vaccine (Live attenuated) Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 0130N145A | July 2021 | Dec 2023 | 30.11.2021 | 25,015 | |
| 127 | 125/2021/LR | Haemophillus Influenzae Type b Conjugate vaccine Single dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 1141M006B | April 2021 | March 2024 | 02.21.2021 | 215 | |
| 128 | 126/2021/LR | Diphtheria Tetanus vaccine for Adults and adolescents 10 dose vial (0.5ml) | Serum Institute of India Pvt. Ltd., India | 2331L024D | Aug 2021 | July 2024 | 02.21.2021 | 2,015 | |
| 129 | 127/2021/LR | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd., India | 0371G059 | June 2021 | May 2023 | 02.21.2021 | 2,515 | |
| 130 | 128/2021/LR | Adsorbed Tetanus vaccine BP Single dose (0.5ml) | Serum Institute of India Pvt. Ltd., India | 2590I007B | March 2021 | Feb 2024 | 02.21.2021 | 40,515 | |
| 131 | 129(1)/2021/LR 129(2)/2021/LR | Snake Venom Antiserum I.P. | Vins Bioproducts Ltd India | 01AS21072 | 10/2021 | 09/2025 | 01.12.2021 | 5,154 | |
| 132 | 129(2)/2021/LR | Snake Venom Antiserum I.P. | Vins Bioproducts Ltd India | 01AS21073 01AS21074 01AS21075 01AS21076 01AS21077 01AS21078 01AS21079 | 10/2021 | 09/2025 | 02.12.2021 | 29,846 | |
| 133 | 130/2021/LR | Japanese Encephalitis Vaccine, Live single dose vial | Chengdu Institute of Biological Products Co. Ltd., China | 202105A078-2 | 24.05.2021 | 23.05.2023 | 02.12.2021 | 10,000 | |
| 134 | 131/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL3206 | 23.10.2021 | 30.06.2022 | 10.12.2021 | 31,200 | |
| 135 | 132/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL9994 | 25.10.2021 | 30.06.2022 | 14.12.2021 | 40,755 | |
| 136 | 133/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL9994 | 25.10.2021 | 30.06.2022 | 30.12.2021 | 71,175 | |
| 137 | 134/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL9994 | 25.10.2021 | 30.06.2022 | 14.12.2021 | 40,755 | |
| 138 | 135/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FL9994 | 25.10.2021 | 30.06.2022 | 14.12.2021 | 71,175 | |
| 139 | 136/2021/LR | Measles, Mumps and Rubella vaccine, Live, Attenuated (Freeze-dried) 10 dose vial | Serum Institute of India Pvt. Ltd., India | 0161N016 | SEP 2021 | FEB 2024 | 10.12.2021 | 12,000 | |
| 140 | 137/2021/LR | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2821Q019A | July 2021 | June 2023 | 10.12.2021 | 15,000 | |
| 141 | 138/2021/LR | Hepatitis B (rDNA) Vaccine 20mcg/ml (Adult- single dose) | GlaxoSmithKline Biologicals SA 89,Rue de I' Institut, BE 1330,Rixensart,Belgium | AHBVC978AC | 01.10.2020 | 30.09.2023 | 17.06.2021 | 30,000 | |
| 142 | 139/2021/LR | Measles, Mumps and Rubella vaccine, Live, Attenuated (Freeze-dried) 1 dose vial | Serum Institute of India Pvt. Ltd., India | 0131W017 | SEP 2021 | FEB 2024 | 17.12.2021 | 12,010 | |
| 143 | 140/2021/LR | Gam-COVID-Vac Component 1 Single dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | 17621B2F2 | OCT 2021 | April 2022 | Pending | 2,500 | Awaiting for english translation of the certificate of analysis |
| 144 | 141/2021/LR | Gam-COVID-Vac Component II Single dose ampoule | Pharmstandard-Ufa Vita JSC / GENERIUM JSC, Russia | 23921B3F2 | SEP 2021 | March 2022 | Pending | 2,500 | Awaiting for english translation of the certificate of analysis |
| 145 | 142/2021/LR | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd. India | 0371G046 | Jun 2021 | May 2023 | 21.12.2021 | 25,000 | |
| 146 | 143/2021/LR | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2331X003B | March 2021 | Feb 2024 | 21.12.2021 | 15,000 | |
| 147 | 144/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM2957 | 09.11.2021 | 31.07.2022 | 21.12.2021 | 68,250 | |
| 148 | 145/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM2957 | 09.11.2021 | 31.07.2022 | 21.12.2021 | 68,640 | |
| 149 | 146/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 23.12.2021 | 23,400 | |
| 150 | 147/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 23.12.2021 | 23,400 | |
| 151 | 148/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 23.12.2021 | 23,400 | |
| 152 | 149/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 23.12.2021 | 23,400 | |
| 153 | 150/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 23.12.2021 | 23,400 | |
| 154 | 151/2021/LR | Rabies Vaccine B.P. 'Rab' Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute (A division of Indian Immunologicals Ltd), Tamil Nadu, India | 21URAB036 21URAB040 | July 2021 Aug 2021 | June 2024 July 2024 | 30.12.2021 | 70,203 49,797 | |
| 155 | 152/2021/LR | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd., India | 0371G059 | June 2021 | May 2023 | 28.21.2021 | 2,305 | |
| 156 | 153/2021/LR | Hepatitis B Vaccine (rDNA) Adult Single dose vial | Serum Institute of India Pvt. Ltd., India | 0341Q009B | July2021 | June 2024 | 28.21.2021 | 405 | |
| 157 | 154/2021/LR | Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b conjugate vaccine Adsorbed Single dose vial | Serum Institute of India Pvt. Ltd., India | 2851Y020E | July 2021 | Dec 2023 | 28.21.2021 | 1,005 | |
| 158 | 155/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 19,500 | |
| 159 | 156/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 3,900 | |
| 160 | 157/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 35,100 | |
| 161 | 158/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 23,400 | |
| 162 | 159/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 35,100 | |
| 163 | 160/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 23,400 | |
| 164 | 161/2021/LR | COMIRNATY (COMIRNATY 195*0.45ml GVL PUU-F2-BNT EU) COVID-19 mRNA Vaccine | PFIZERMANUFACTURING BELGIUM NV,RIJKSWEG 12,B-2870,PUURS,BELGIUM | FM7532 | 28.10.2021 | 30.06.2022 | 30.12.2021 | 9,750 | |
| 165 | 162/2021/LR | Combined Diphtheria,Tetanus, Acellular Pertussis, Hepatitis B and Inactivated Polio Vaccine + Adsorbed Haemophilus influenzae type B Vaccine, Infanrix hexa Single dose vial | GlaxoSmithKline Biologicals, Belgium | A21CE003B | April 2021 | March2024 | 29.12.2021 | 22,380 | |
| No. of vaccine/serum lots released = 170 | |||||||||
| No. of vaccine/serum lots failed to pass lot release = 0 | |||||||||
| No. of vaccine/serum lots tested following a break in the cold chain, adverse effects following immunization or vaccine failure = 0 | |||||||||
|
Serial |
Product Name | Manufacture | Lot No | Manufacturing date | Expiry date | Lot release certificate No | Date of release | No of vials released |
| 1 | Varicella Vaccine (live), Varilrix Single dose vial | GlaxoSmithKline Biologicals Rixensart, Belgium | A70CD366A | Mar 2019 | Feb 2021 | 44/2019/LR | 05.02.2120 | 500 |
| 2 | Inactivated Poliomyelitis vaccine 05 dose vial (25 dose as ID adm) | Bilthoven Biologicals B.V.,The Netherlands |
1913005A, 1922002A, 1941002A |
19.03.2019, 26.04.2019, 29.08.2019 |
18.03.2022, 23.04.2022, 22.08.2022 |
51/2019/LR | 06.01.2020 |
119, 4923, 17918 |
| 3 | Adsorbed Tetanus Vaccine B.P.Single dose vial | Serum Institute of India Pvt. Ltd.,India |
25991003A, 25991003B |
Feb 2019 | Jan 2022 | 01/2020/LR | 16.01.2020 |
160500, 139500 |
| 4 | Rabies Vaccine for Human Use (vero cell) freeze dried, SPEEDA | Liaoning Cheng Da Biotechnology Co., Ltd., China. | 201905141 | May 2019 | Apr 2022 | 02/2020/LR | 22.01.2020 | 55000 |
| 5 | Hepatitis B Vaccine (rDNA) Single dose vial | Serum Institute of India Pvt. Ltd.,India | 0349Q001C | Jan 2019 | Dec 2021 | 03/2020/LR | 16.01.2020 | 25000 |
| 6 | Rabies Vaccine B.P. 'Rab' Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute (A division of Indian Immunologicals Ltd), India |
19URAB068, 19URAB073 |
Aug 2019 | Jul 2022 | 04/2020/LR | 21.01.2020 |
39627, 15373 |
| 7 | Rabies Vaccine for Human Use (vero cell) freeze dried, SPEEDA | Liaoning Cheng Da Biotechnology Co., Ltd., China. |
201905141, 201908258 |
May 2019 Aug 2019 | Apr 2022 Jul 2022 | 05/2020/LR | 07.02.2020 |
33640, 31360 |
| 8 | Measles, Mumps and Rubella vaccine,Live, Attenuated (Freeze-dried)10 dose vial | Serum Institute of India Pvt. Ltd.,India | 0168N024 | Jun 2019 | Nov 2021 | 06/2020/LR | 27.02.2020 | 40000 |
| 9 | Rabies Vaccine for Human Use (vero cell) freeze dried, SPEEDA | Liaoning Cheng Da Biotechnology Co., Ltd., China. | 201908260 | Aug 2019 | Jul 2022 | 07/2020/LR | 11.03.2020 | 60000 |
| 10 | BCG Vaccine 20 dose vial | Serum Institute of India Pvt. Ltd.,India | 0379G087 | Nov 2019 | Oct 2021 | 08/2020/LR | 04.03.2020 | 20000 |
| 11 | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt. Ltd.,India | 2339X029A | Oct 2019 | Sep 2022 | 09/2020/LR | 04.03.2020 | 20000 |
| 12 | Rabies Vaccine for Human Use (vero cell) freeze dried, SPEEDA | Liaoning Cheng Da Biotechnology Co., Ltd., China. |
201908260 ,201908262 |
Aug 2019 | Jul 2022 | 10/2020/LR | 15.05.2020 |
26220 ,28780 |
| 13 | Hepatitis B Vaccine (rDNA) Single dose vial | Serum Institute of India Pvt. Ltd.,India | 0349Q007C | Sep 2019 | Aug 2022 | 11/2020/LR | 11.05.2020 | 23000 |
| 14 | Human Papillomavirus Quadrivalent Vaccine, Gardasil Single dose vial | Merck Sharp & Dohme Corp.,USA | S036739 | 25.02.2019 | 25.02.2022 | 12/2020/LR | 10.06.2020 | 75000 |
| 15 | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt. Ltd.,India | 2339L032C | Dec 2019 | Nov 2022 | 13/2020/LR | 11.06.2020 | 20000 |
| 16 | Diphtheria, Tetanus and Pertussis Vaccine Adsorbed 10 dose vial | Serum Institute of India Pvt.Ltd.,India | 2829X022A | Jan 2020 | Dec 2021 | 14/2020/LR | 11.06.2020 | 20000 |
| 17 | Japanese Encephalitis Vaccine, Live 5 dose vial | Chengdu Institute of Biological Products Co. Ltd., China | 201911C053-2 | 23.11.2019 | 22.11.2021 | 15/2020/LR | 15.06.2020 | 50000 |
| 18 | Rabies Vaccine B.P. 'Rab' Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute (A division of Indian Immunologicals Ltd), TamilNadu, India |
19URAB093, 19URAB109, 20URAB004, 20URAB006 |
Nov 2019, Jan 2020, Jan 2020, Jan 2020 |
Oct 2022 Dec 2022 Dec 2022 Dec 2022 | 16/2020/LR | 11.06.2020 | 22418 70305 70298 16979 |
No. of vaccine/serum lots released = 27
No. of vaccine/serum lots failed to pass lot release = 0
No. of vaccine/serum lots tested following a break in the cold chain, adverse effects following immunization or vaccine failure = 0
| Sr. No | Product Name | Manufacture | Lot No | Manufacturing date | Expiry date | Lot release certificate No | Date of release |
| 1 | Varicella Vaccine - Varilrix | Glaxo SmithKline Biologicals, Belgium | A70CD239A | Mar 2018 | Feb 2020 | 42/2018/LR | 01.01.2019 |
| 2 | Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Menactra | Sanofi Pasteur Inc, USA | U5961AG | 14.07.2017 | 21.07.2019 | 27/2018/LR | 03.01.2019 |
| 3 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 18URAB094 | Nov 2018 | Oct 2021 | 01/2019/LR | 14.01.2019 |
| 4 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 18URAB099 | Nov 2018 | Oct 2021 | 02/2019/LR | 31.01.2019 |
| 5 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 18URAB099 | Nov 2018 | Oct 2021 | 03/2019/LR | 15.02.2019 |
| 6 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 18URAB103 | Dec 2018 | Nov 2021 | 03/2019/LR | 15.02.2019 |
| 7 | Rabies Vaccine for Human Use (Vero Cell), Freeze-dried - SPEEDA | Liaoning Cheng Da Biotechnology Co., Ltd., China. | 201712427 | Dec 2017 | Nov 2020 | 04/2019/LR | 21.02.2019 |
| 8 | Yellow Fever Vaccine (Live) | Sanofi Pasteur S A, France | R3C963V | 22.03.2018 | 02-2021 | 05/2019/LR |
25.02.2019 |
| 9 | Bivalent Oral Poliomyelitis Vaccine | Sanofi Pasteur S A, France | R3D60 | 06.04.2018 | 31.03.2020 | 06/2019/LR | 25.02.2020 |
| 10 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 18URAB109 | Dec 2018 | Nov 2021 | 07/2019/LR | 10.04.2019 |
| 11 | Rabies vaccine, Verorab | Sanofi Pasteur, France | R1B97IV | 03.04.2018 | Mar 2021 | 08/2019/LR | 24.06.2019 |
| 12 | Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine | Human Biologicals Institute, India | 19URAB005 | Jan 2019 | Dec 2021 | 09/2019/LR | 09.04.2019 |
| 13 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818010 | 03/2018 | 02/2020 | 10/2019/LR | 17.04.2019 |
| 14 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818011 | 03/2018 | 02/2020 | 10/2019/LR | 17.04.2019 |
| 15 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818020 | 07/2018 | 06/2020 | 10/2019/LR | 17.04.2019 |
| 16 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818021 | 07/2018 | 06/2020 | 10/2019/LR | 17.04.2019 |
| 17 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818024 | 08/2018 | 07/2020 | 10/2019/LR | 17.04.2019 |
| 18 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818026 | 09/2018 | 08/2020 | 10/2019/LR | 17.04.2019 |
| 19 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06818027 | 09/2018 | 08/2020 | 10/2019/LR | 17.04.2019 |
| 20 | Human Papillomavirus Quadrivalent Vaccine - Gardasil | Merck Sharp and Dohme Corp, USA | S002318 | 27.06.2018 | 27.06.2021 | 11/2019/LR | 06.05.2019 |
| 21 | Inactivated Poliomyelitis vaccine | Bilthoven Biologicals B.V., The Netherlands | 1901009A | 06.12.2018 | 19.11.2021 | 12/2019/LR | 13.05.2019 |
| 22 | Inactivated Poliomyelitis vaccine | Bilthoven Biologicals B.V., The Netherlands | 1903001A |
10.01.2019 |
17.12.2021 | 12/2019/LR | 13.05.2019 |
| 23 | Inactivated Poliomyelitis vaccine | Bilthoven Biologicals B.V., The Netherlands | 1904002A |
14.01.2019 |
28.11.2021 | 12/2019/LR | 13.05.2019 |
| 24 |
Inactivated Poliomyelitis vaccine |
Bilthoven Biologicals B.V., The Netherlands | 1904003A |
15.01.2019 |
28.11.2021 | 12/2019/LR | 13.05.2019 |
| 25 |
Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL |
Bharat Serums and Vaccines Ltd., India | A06818009 |
03/2018 |
02/2020 | 13/2019/LR | 09.05.2019 |
| 26 |
Diphtheria, Tetanus and Pertussis Vaccine Adsorbed |
Serum Institute of India Pvt.Ltd., India |
2828X010B |
Nov 2018 |
Oct 2020 | 14/2019/LR | 22.05.2019 |
| 27 |
Dephtheria and Tetanus Vaccine, Adsorbed (Pediatric) |
Serum Institute of India Pvt.Ltd., India |
2458L003A |
Dec 2018 |
Nov 2021 | 15/2019/LR | 22.05.2019 |
| 28 |
Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents |
Serum Institute of India Pvt.Ltd., India |
2338L024A |
Nov 2018 |
Oct 2021 | 16/2019/LR | 22.05.2019 |
| 29 |
Rabies Vaccine for Human Use (Vero Cell), Freeze-dried - SPEEDA |
Liaoning Cheng Da Biotechnology Co., Ltd., China. |
201809279 |
Sep 2018 |
Aug 2021 | 17/2019/LR | 24.05.2019 |
| 30 |
Rabies Vaccine B.P. 'Rab' - Abhayrab Purified vero cell rabies vaccine |
Human Biologicals Institute, India |
19URAB010 |
Feb 2019 |
Jan 2022 | 18/2019/LR | 30.05.2019 |
| 31 |
Pneumococcal Vaccine, polyvalent - Pneumovax*23 |
Merck Sharp and Dohme Corp, U.S.A. |
S007700 |
01.09.2018 |
01.09.2020 | 19/2019/LR | 10.06.2019 |
| 32 |
BCG Vaccine |
Serum Institute of India Pvt.Ltd., India |
0378G154 |
Jan 2019 |
Dec 2020 | 20/2019/LR | 24.06.2019 |
| 33 |
Japanese Encephalitis Vaccine, Live |
Chengdu Institute of Biological Products Co. Ltd., China |
201901C001-2 |
04.01.2019 |
03.01.2021 | 21/2019/LR | 24.06.2019 |
| 34 |
Hepatitis B vaccine (rDNA) |
Serum Institute of India Pvt.Ltd., India |
0348Y017C |
Oct 2018 |
Sep 2021 | 23/2019/LR | 24.06.2019 |
| 35 |
Snake Venom Antiserum I.P. |
Bharat Serums and Vaccines Ltd, India |
A05317153 |
Oct 2017 |
Sep 2021 | 24/2019/LR | 24.06.2019 |
| 36 |
Snake Venom Antiserum I.P. |
Bharat Serums and Vaccines Ltd, India |
A05317154 |
Oct 2017 |
Sep 2021 | 24/2019/LR | 24.06.2019 |
| 37 |
Snake Venom Antiserum I.P. |
Bharat Serums and Vaccines Ltd, India |
A05317155 |
Oct 2017 |
Sep 2021 | 24/2019/LR | 24.06.2019 |
| 38 |
Hepatitis B vaccine (rDNA) |
Serum Institute of India Pvt.Ltd., India |
0348X008FE |
Jul 2018 |
Jun 2021 | 25/2019/LR | 25.06.2019 |
|
No. of vaccine/serum lots released = 38 No. of vaccine/serum lots failed to pass lot release = 0 No. of vaccine/serum lots tested following a break in the cold chain, adverse effects following immunization or vaccine failure = 0
|
|||||||
| Serial No | Product Name | Manufacture | Lot No | Manufacturing date | Expiry date | Lot release certificate No | Date of release | No of vials released |
| Meningococcal (Group A,C,Y, W-135) Polysacharide Diphtheria Toxoid Conjugate Vaccine - Menactra Single dose vial | Sanofi Pasteur Inc., USA | U6131AE | 24.01.2018 | 13.02.2020 | 22/2019/LR | 31.07.2019 | 2,000 | |
| 1 | Meningococcal (Group A,C,Y, W-135) Polysacharide Diphtheria Toxoid Conjugate Vaccine - Menactra Single dose vial | Sanofi Pasteur Inc., USA | U6366AH | 11.09.2018 | 26.09.2020 | 26/2019/LR | 31.07.2019 | 1,500 |
| 2 | Rabies Vaccine B.P. 'Rab' Abhayrab Purified vero cell rabies vaccine ID administration 5 dose vial (IM administration single dose vial) | Human Biologicals Institute, India | 19URAB022 | Mar 2019 | Feb 2022 | 27/2019/LR | 09.07.2019 | 40,000 |
| 3 | Adsorbed tetanus vaccine B.P.Single dose vial | Biological E Ltd., India | 220801718C 220801818A 220801818D |
Jul 2018 Aug 2018 Aug 2018 |
Jun 2021 Jul 2021 Jul 2021 |
28/2019/LR | 09.07.2019 |
10,000 92,420 94,631 |
| 4 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums and Vaccines Ltd., India | A06819003 | Jan 2019 | Dec 2020 | 29/2029/LR | 07.08.2019 | 20,000 |
| 5 | Yellow Fever Vaccine (Live) Single dose vial | Sanofi Pasteur S A, France | R3L025V | 26.09.2018 | Aug 2021 | 30/2019/LR | 22.07.2019 | 2,300 |
| 6 | Diphtheria, Tetanus, Pertussis (whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b conjugate Vaccine Adsorbed 10 dose vial | Biological E Ltd., India | 220101519A | Mar 2019 | Aug 2021 | 31/2019/LR | 16.08.2019 | 50,000 |
| 7 | Adsorbed tetanus vaccine B.P.Single dose vial | Serum Institute of India Pvt.Ltd., India |
2598A005G 2599I002E 2599I004A |
Dec 2018 Jan 2019 Feb 2019 |
Nov 2021 Dec 2021 Jan 2022 |
32/2019/LR | 10.09.2019 |
94,950 109,200 95,850 |
| 8 |
Rabies Vaccine for Human Use (Vero Cell), Freeze-dried - SPEEDA ID administration 5 dose vial (IM administration single dose vial) |
Liaoning Cheng Da Biotechnology Co., Ltd., China. | 201812379 | Dec 2018 | Nov 2021 | 33/2019/LR | 03.09.2019 | 59,560 |
| 9 | Adsorbed tetanus vaccine B.P.10 dose vial | Biological E Ltd., India | 220801218C | May 2018 | Apr 2021 | 34/2019/LR | 12.09.2019 | 20,000 |
| 10 | Measles, Mumps and Rubella Vaccine 10 dose vial | Serum Institute of India Pvt.Ltd., India | 0168N023 | May 2019 | Oct 2021 | 35/2019/LR | 12.09.2019 | 40,000 |
| 11 | Diphtheria, Tetanus and Pertussis Vaccine Adsorbed 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2829X003A | Apr 2019 | Mar 2021 | 36/2019/LR | 20.09.20196 | 15,000 |
| 12 | Human Papillomavirus Quadrivalent Vaccine - Gardasil Single dose vial | Merck Sharp & Dohme B. V., USA |
S019955 | 02.12.2018 | 02.12.2021 | 37/2019/LR | 27.09.2019 | 50,000 |
| 13 | Japanese Encephalitis Vaccine, Live 5 dose vial | Chengdu Institute of Biological Products Co. Ltd., China | 201903C019-2 | 09.03.2019 | 08.03.2021 | 38/2019/LR | 27.09.2019 | 40,000 |
| 14 | Bivalent Oral Poliomyelitis Vaccine 20 dose vial | Sanofi Pasteur, France | R3M47 | 06.11.2018 | Oct 2020 | 39/2019/LR | 01.10.2019 | 40,000 |
| 15 | Diphtheria and Tetanus Vaccine Adsorbed for adult and adolescents 10 dose vial | Serum Institute of India Pvt.Ltd., India | 2339L015G | May 2019 | Apr 2022 | 40/2019/LR | 14.10.2019 | 10,000 |
| 16 | Diphtheria, Tetanus, Pertussis (whole cell), Hepatitis B (rDNA) and Haemophilus Influenzae type b conjugate Vaccine Adsorbed 10 dose vial | Biological E Ltd., India | 220106819A | Jun 2019 | Nov 2021 | 41/2019/LR | 08.11.2019 | 50,000 |
| 17 | Rabies Vaccine for Human Use (Vero Cell), Freeze-dried - SPEEDA ID administration 5 dose vial (IM administration single dose vial) | Liaoning Cheng Da Biotechnology Co., Ltd., China. | 201901032 | Jan 2019 | Dec 2021 | 42/2019/LR | 23.10.2019 | 60,000 |
| 18 | Rabies antiserum, Equine origin - Equirab 1000 IU/5 mL | Bharat Serums & Vaccines Ltd., India |
A06819009 | Aug 2019 | Jul 2021 | 43/2019/LR | 11.11.2019 | 20,000 |
| 19 | Human Papillomavirus Quadrivalent Vaccine - Gardasil Single dose vial | Merck Sharp & Dohme B. V., USA | S022939 | 05.12.2018 | 05.12.2021 | 45/2019/LR | 15.11.2019 | 175,000 |
| 20 | Yellow Fever Vaccine (Live)Single dose vial | Sanofi Pasteur S A, France | R3L27 | 08.10.2018 | Sep 2021 | 46/2019/LR | 20.12.2019 | 2,000 |
| 21 | Rabies Vaccine for Human Use (Vero Cell), Freeze-dried - SPEEDA ID administration 5 dose vial (IM administration single dose vial) | Liaoning Cheng Da Biotechnology Co., Ltd., China. |
201812379 201902062 |
Dec 2018 Feb 2019 |
Nov 2021 Jan 2022 |
47/2019/LR | 09.12.2019 | 415 59, 585 |
| 22 | Pneumococcal Vaccine, polyvalent (Pneumovax*23)Single dose vial | Merck Sharp & Dohme Corp,U.S.A. | S029118 | 16.04.2019 | 16.04.2021 | 48/2019/LR | 12.12.2019 | 1,200 |
| 23 | Bivalent Oral Poliomyelitis Vaccine 20 dose vial | Sanofi Pasteur, France | T3D50 | 29.04.2019 | March 2021 | 49/2019/LR | 27.12.2019 | 40,000 |
| 24 | Adsorbed Tetanus Vaccine B. P.10 dose vial | Biological E Ltd., India | 220800619C | June 2019 | May 2022 | 50/2019/LR | 27.12.2019 | 20,000 |
|
No. of vaccine/serum lots released = 30 No. of vaccine/serum lots failed to pass lot release = 0 No. of vaccine/serum lots tested following a break in the cold chain, adverse effects following immunization or vaccine failure = 0 |
||||||||